Canada· CA-DIN-02456532

BEPREVE

A ophthalmologicals product containing bepotastine besilate, registered in Canada by BAUSCH & LOMB INC. The same ATC class is registered in 3 of our 19 countries.

ATC S01

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedBEPREVEATCS01REGISTER NO.CA-DIN-02456532PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Bepotastine besilate is registered in 3 of 19 countries.

Countries holding a registration under ATC S01 (ophthalmologicals), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 1 of them publish a price we can compare per daily dose

Bepotastine besilate · ATC S01

3 / 19 countries

  • Canada
  • Ireland
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
BEPOTASTINE BESILATE
Manufacturer
BAUSCH & LOMB INC
Country
Canada (CA)
ATC code
S01
ATC class
OPHTHALMOLOGICALS
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Bepotastine besilate in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bepotastine besilate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/27bea012-c3ae-4247-84f3-a85722047603
GET /v1/drugs/27bea012-c3ae-4247-84f3-a85722047603?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02456532",
  "form": "SOLUTION",
  "class": "Human",
  "routes": [
    "OPHTHALMIC"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "S01",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "94350",
  "strengths": [
    "1.5 %"
  ],
  "ahfs_class": null,
  "substances": [
    "BEPOTASTINE BESILATE"
  ],
  "product_categorization": null
}

See everything about bepotastine besilate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.